As­traZeneca nix­es $8B So­bi buy­out over fears a for­mer drug would be sold to ri­vals — re­port

As­traZeneca has re­port­ed­ly tanked a deal that would have tak­en high-pro­file rare dis­ease com­pa­ny So­bi pri­vate over fears its res­pi­ra­to­ry drugs would fall in­to the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER